{"organizations": [], "uuid": "4faeef9868470d112d13ecb7d2ada2f8f3917d5c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bioscrip-reports-q4-preliminary-ne/brief-bioscrip-reports-q4-preliminary-net-revenue-of-182-6-mln-idUSASB0C9FM", "country": "US", "domain_rank": 408, "title": "BRIEF-BioScrip Reports Q4 Preliminary Net Revenue Of $182.6 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.994, "site_type": "news", "published": "2018-03-08T21:13:00.000+02:00", "replies_count": 0, "uuid": "4faeef9868470d112d13ecb7d2ada2f8f3917d5c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bioscrip-reports-q4-preliminary-ne/brief-bioscrip-reports-q4-preliminary-net-revenue-of-182-6-mln-idUSASB0C9FM", "ord_in_thread": 0, "title": "BRIEF-BioScrip Reports Q4 Preliminary Net Revenue Of $182.6 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bioscrip inc", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8 (Reuters) - Bioscrip Inc:\n* BIOSCRIP REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* QTRLY PRELIMINARY NET REVENUE OF $182.6 MILLION, INCLUDING CORE PRODUCT MIX OF 75.7%, COMPARED TO 69.6% IN PRIOR YEAR QUARTER\n* FOR FULL YEAR 2018, COMPANY IS ESTABLISHING REVENUE GUIDANCE OF $710 MILLION TO $720 MILLION\n* FOR FULL YEAR 2018, CO SEES ADJUSTED EBITDA GUIDANCE OF $54 MILLION TO $58 MILLION\n* EXPECTS CAPITAL EXPENDITURES IN 2018 TO BE BETWEEN $12 MILLION AND $14 MILLION\n* PRELIMINARY Q4 NET LOSS FROM CONTINUING OPERATIONS OF $1.2 MILLION\n* BIOSCRIP - SEES 2018 LOSS PER SHARE $0.41 TO $0.34\n* FY2018 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $716.2 MILLION — THOMSON REUTERS I/B/E/S\n* Q4 EARNINGS PER SHARE VIEW $-0.08, REVENUE VIEW $171.4 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T21:13:00.000+02:00", "crawled": "2018-03-09T14:29:48.005+02:00", "highlightTitle": ""}